Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $7.17 billion. The enterprise value is $9.16 billion.
| Market Cap | 7.17B |
| Enterprise Value | 9.16B |
Important Dates
The last earnings date was Wednesday, October 23, 2024, before market open.
| Earnings Date | Oct 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 103.48 million shares outstanding. The number of shares has decreased by -2.29% in one year.
| Current Share Class | 103.48M |
| Shares Outstanding | 103.48M |
| Shares Change (YoY) | -2.29% |
| Shares Change (QoQ) | -1.08% |
| Owned by Insiders (%) | 2.52% |
| Owned by Institutions (%) | 99.45% |
| Float | 100.82M |
Valuation Ratios
The trailing PE ratio is 9.19 and the forward PE ratio is 7.62.
| PE Ratio | 9.19 |
| Forward PE | 7.62 |
| PS Ratio | 0.94 |
| Forward PS | 0.90 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | 485.05 |
| P/OCF Ratio | 261.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.84, with an EV/FCF ratio of 619.30.
| EV / Earnings | 11.26 |
| EV / Sales | 1.17 |
| EV / EBITDA | 7.84 |
| EV / EBIT | 8.12 |
| EV / FCF | 619.30 |
Financial Position
The company has a current ratio of 7.46, with a Debt / Equity ratio of 0.39.
| Current Ratio | 7.46 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 1.87 |
| Debt / FCF | 150.34 |
| Interest Coverage | 151.83 |
Financial Efficiency
Return on equity (ROE) is 14.97% and return on invested capital (ROIC) is 9.27%.
| Return on Equity (ROE) | 14.97% |
| Return on Assets (ROA) | 7.94% |
| Return on Capital (ROIC) | 9.27% |
| Revenue Per Employee | $2.80M |
| Profits Per Employee | $290,515 |
| Employee Count | 2,800 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 0.98 |
Taxes
In the past 12 months, TMHC has paid $258.33 million in taxes.
| Income Tax | 258.33M |
| Effective Tax Rate | 24.05% |
Stock Price Statistics
The stock price has increased by +53.08% in the last 52 weeks. The beta is 1.97, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | +53.08% |
| 50-Day Moving Average | 69.31 |
| 200-Day Moving Average | 61.60 |
| Relative Strength Index (RSI) | 48.37 |
| Average Volume (20 Days) | 900,527 |
Short Selling Information
The latest short interest is 2.17 million, so 2.10% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short Previous Month | 2.64M |
| Short % of Shares Out | 2.10% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 2.95 |
Income Statement
In the last 12 months, TMHC had revenue of $7.83 billion and earned $813.44 million in profits. Earnings per share was $7.54.
| Revenue | 7.83B |
| Gross Profit | 1.92B |
| Operating Income | 1.13B |
| Pretax Income | 968.08M |
| Net Income | 813.44M |
| EBITDA | 1.17B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | $7.54 |
Balance Sheet
The company has $256.45 million in cash and $2.22 billion in debt, giving a net cash position of -$1.97 billion or -$19.00 per share.
| Cash & Cash Equivalents | 256.45M |
| Total Debt | 2.22B |
| Net Cash | -1.97B |
| Net Cash Per Share | -$19.00 |
| Equity (Book Value) | 5.72B |
| Book Value Per Share | 55.14 |
| Working Capital | 6.74B |
Cash Flow
In the last 12 months, operating cash flow was $27.44 million and capital expenditures -$12.65 million, giving a free cash flow of $14.78 million.
| Operating Cash Flow | 27.44M |
| Capital Expenditures | -12.65M |
| Free Cash Flow | 14.78M |
| FCF Per Share | $0.14 |
Margins
Gross margin is 24.54%, with operating and profit margins of 14.39% and 10.39%.
| Gross Margin | 24.54% |
| Operating Margin | 14.39% |
| Pretax Margin | 13.71% |
| Profit Margin | 10.39% |
| EBITDA Margin | 14.92% |
| EBIT Margin | 14.39% |
| FCF Margin | -2.64% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.29% |
| Shareholder Yield | 2.29% |
| Earnings Yield | 11.34% |
| FCF Yield | 0.21% |
Analyst Forecast
The average price target for TMHC is $77.33, which is 11.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $77.33 |
| Price Target Difference | 11.59% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 3.72 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.72 |
| Piotroski F-Score | 4 |